Home > Animal Health & Nutrition > Veterinary Pharmaceuticals > Veterinary Renal Disease Market

Veterinary Renal Disease Market Size

Report ID: GMI8426
Published Date: Mar 2024
Report Format: PDF

Download Free Sample

Veterinary Renal Disease Market Size

Veterinary Renal Disease Market size was valued at USD 15.9 billion in 2023 and is predicted to reach USD 26.5 billion by 2032, showcasing growth of 5.9% from 2024 to 2032 period. The growth of this market can be attributed to factors such as rise in pet ownership and advances in animal diagnostics.

To get key market trends

Download Free Sample

Also, rising prevalence of renal diseases in animals, growing focus on renoprotective diets of animals, and increased awareness among pet owners and veterinarians are expected to fuel the growth market. According to the report published by the International Renal Interest Society in 2023, the prevalence of CKD is estimated to be 0.5-1% in dogs and 1-3% in cats. However, it increases with age, specifically in cats with reported prevalence of 80% in the geriatric cat population. Thus, adoption of renal disease treatment and diagnosis in such population will spur the market progress.

Veterinary renal disease refers to any condition or disease affecting the kidneys of animals, including domestic pets and livestock. These conditions may involve structural abnormalities, functional disturbances, or inflammatory processes within the kidneys, leading to impaired kidney function and potential complications affecting other organ systems.

Veterinary Renal Disease Market Report Attributes
Report Attribute	Details
Base Year:	2023
Veterinary Renal Disease Market Size in 2023:	USD 15.9 Billion
Forecast Period:	2024 - 2032
Forecast Period 2024 - 2032 CAGR:	5.9%
2032 Value Projection:	USD 26.5 Billion
Historical Data for:	2018 - 2023
No. of Pages:	210
Tables, Charts & Figures:	368
Segments covered:	Type, Animal Type, Indication, and Region
Growth Drivers:	Advancements in veterinary medicine Increasing prevalence of renal diseases in companion animals Growing awareness among pet owners and veterinarians Rising demand for renoprotective diets
Pitfalls & Challenges:	Off-label use of drugs in veterinary treatment

Learn more about the key segments shaping this market

Download Free Sample

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Veterinary renal disease market size was USD 15.9 billion in 2023 and is expected to register 5.9% CAGR from 2024-2032 owing to the rise in pet ownership and advances in animal diagnostics worldwide.

The treatment segment held 67.3% share in 2023 and is expected to register an appreciable CAGR from 2024-2032 due to the growing prevalence of kidney disorders in animals, that increases the demand for effective treatment options.

North America veterinary renal disease industry reached USD 7 billion in 2023 and is expected to register a commendable CAGR from 2024-2032 due to the increasing emphasis on comprehensive animal healthcare in the region.

Dechra Pharmaceuticals, Elanco Animal Health Incorporated, General Mills Inc., Hill's Pet Nutrition, Inc., IDEXX Laboratories, Inc., The J.M. Smucker Company, Mars Incorporated, Merck & Co., Inc., and Nestle Purina, are some of the major veterinary renal disease companies worldwide.